abstract Tobacco use and tobacco smoke exposure are among the most important preventable causes of premature disease, disability, and death and therefore constitute a major pediatric health concern. The pediatric primary care setting offers excellent opportunities to prevent tobacco use in youth and to deliver cessation-related treatment to youth and parents who use tobacco. This report updates a "state-of-the-art" article published a decade ago on office-based interventions to address these issues. Since then there has been marked progress in understanding the nature, onset, and trajectories of tobacco use and nicotine addiction in youth with implications for clinical practice. In addition, clinicians need to remain abreast of emerging nicotine delivery systems, such as electronic cigarettes, that may influence uptake or continuation of smoking. Although evidence-based practice guidelines for treating nicotine addiction in youth are not yet available, research continues to build the evidence base toward that goal. In the interim, practical guidelines are available to assist clinicians in addressing nicotine addiction in the pediatric clinical setting. This article reports current practices in addressing tobacco in pediatric primary care settings. It reviews our increasing understanding of youth nicotine addiction, summarizes research efforts on intervention in the past decade and additional research needed going forward, and provides practical guidelines for pediatric health care providers to integrate tobacco use prevention and treatment into their clinical practice. Pediatric providers can and should play an important role in addressing tobacco use and dependence, both in the youth they care for and in parents who use tobacco.
Tobacco use and tobacco smoke exposure are among the most important preventable causes of premature disease, disability, and death. Ninety percent of adult smokers initiate tobacco use before age 18 years, and 99% do so before age 26. 1 Although the incidence of initiation declines with age, 86% of young people who initiate smoking before age 24 years do so during high school. 2 More than 3.6 million US youth (15.8%) currently smoke 3 ; 80% will continue to smoke into adulthood, and, among those who do, one-half will die earlier than their nonsmoking peers. 4 Youth smoking causes nicotine addiction, reduced lung function, asthma, and early atherosclerosis. 5 Almost one-quarter (24.3%) of high school students report tobacco use, and many youth use both cigarette and noncigarette tobacco products. 3, 6, 7 In fact, use of electronic nicotine delivery devices (ENDS) is rapidly escalating among youth, and there is considerable concern that ENDS could increase progression to daily smoking and reduce cessation. 8 Parental tobacco use is also of great concern because it harms the health of their children and increases the likelihood of initiation. 9 Pediatric health care providers have unique opportunities to prevent tobacco use initiation and nicotine addiction in their patients, identify current tobacco use in both youth and parents (and other caregivers), and initiate or refer for treatment. Here we update a "state-of-the-art" report published a decade ago. 10 Specifically, we (1) describe current frequency of practice in addressing tobacco in pediatric primary care settings and barriers to practice, (2) describe what is known about nicotine dependence in youth, (3) summarize research efforts on intervention in the past decade and additional research needed going forward, and (4) provide practical guidelines for clinicians to integrate intervention into their clinical practice. Although most of the literature in this area refers to cigarette smoking, the most prevalent form of tobacco use in the United States, the term "tobacco use" as used here includes other nicotine delivery devices such as ENDs and spit tobacco, except when referring to studies specifically addressing cigarette smoking.
TOBACCO-RELATED PRACTICE AND BARRIERS IN PEDIATRIC PRIMARY CARE SETTINGS
Youth identify physicians as their preferred information source regarding smoking and quitting smoking, 11, 12 and parents are supportive of pediatricians screening and counseling for parental smoking. 13, 14 Given that parental smoking is strongly associated with adolescent smoking, 15 pediatricians are in an excellent position to advise parents who smoke to stop, both for their child's health as well as their own. However, the frequency of addressing tobacco in pediatric primary care has remained low, and many barriers still need to be addressed.
Frequency of Counseling
Surveys of American Academy of Pediatrics (AAP) members in 2004 (n = 879) and 2010 (n = 887) 16 revealed few changes over time in the frequency of pediatricians providing tobacco-related advice or assistance to parents and youth. Most pediatricians (85% in 2004 vs 81% in 2010) advised their adolescent patients who smoke to quit, but only a third (34% vs 32%) discussed quit strategies; fewer (17% vs 18%) recommended nicotine replacement medications. 16 Approximately half (56% vs 48%) reported helping adolescents assess their reasons for and against continuing to smoke, 20% vs 15% provided print or other quit materials, and 18% vs 13% referred their patients to a quitline or cessation program (all P , .05). 16 Although few pediatricians counseled parents, there were improvements over time: 10% in 2004 vs 14% in 2010 provided educational materials, and 11% vs 16% referred parents to a quitline or cessation program (all P , .05). 16 Despite improvements, most pediatricians did not discuss strategies to quit smoking or provide materials or refer smokers for support, representing a critical missed opportunity. 13, 14 Intervention delivery is infrequent even for vulnerable youth with asthma, chronic illness, and/or from lowincome families. [17] [18] [19] 
Barriers to Counseling
Pediatricians noted that they would be more likely to provide cessation counseling if they believed that counseling is effective (90%), felt more than moderately confident in advising patients on cessation (77%) and the harmful effects of tobacco use (74.1%), and if their adolescent patients were not fearful that parents would be notified (75.6%). 16 Other barriers include competing health issues, limited time, lack of education and training, lack of access to supportive research, concern about alienating their patients, and inadequate reimbursement for delivering preventive services. [20] [21] [22] Several strategies can be helpful in resolving some of these concerns. First, physician delivery of and selfefficacy or confidence in providing tobacco intervention to youth is increased by training. 23 Therefore, increased access to training and information on the harmful effects of tobacco use as well as research on the benefits of provider intervention, receptivity to such intervention, and concrete clinical steps pediatricians can take in addressing tobacco with their adolescent patients would be of value (see Resources for Pediatric Providers later in the article). Second, the use of office system prompts (eg, paper or computerized reminders in patient charts) can improve service delivery for adult smokers, 24 and provision of charting tools improves delivery of preventive services to youth. 25 Concerns regarding reimbursement for cessation efforts for adolescent patients and their parents have historically been valid: despite the availability of billable current procedural terminology (CPT) codes and valid "up coding," there is great variability in insurers reimbursing for these codes. With the Affordable Care Act, however, tobacco cessation is a covered benefit, and counseling for cessation is a clinical quality measure for meaningful use, allowing providers and hospitals to earn incentive payments for meeting electronic health record criteria and objectives. 26 
PREVENTING INITIATION
Pediatric health care providers can help prevent initiation of tobacco use through anticipatory guidance, by helping parents quit smoking, and by using their privileged position to advocate for effective tobacco control policies. Because tobacco promotion increases smoking initiation, 1 pediatric health care providers should ensure that their offices, waiting rooms, and other environments where children's health care is delivered are tobacco free and are free of tobacco advertisements.
A key risk factor for smoking initiation in youth is parental smoking, addressed later in this article. Other factors include minimal parental monitoring, easy access to cigarettes, sibling and friends smoking, impulsivity, use of other tobacco products, alcohol use, stress, and exposure to tobacco promotion. 27 Provider assessment of these key factors is recommended to determine the level of risk for initiation of each patient who is not using tobacco. In addition, clinicians can reinforce nonsmoking by discussing resisting the influence of tobacco advertising and rehearsing refusal skills when offered tobacco by peers (Fig 1) . They can also reinforce that weight reduction through cigarette use is not effective, and address family-related stress issues. See Supplemental Information for additional information on assessing susceptibility to tobacco use initiation and intervention strategies.
TOBACCO DEPENDENCE AND TRAJECTORIES
The developing brain is particularly susceptible to the addictive potential of nicotine. 5 Understanding the nature, onset, and trajectories of tobacco use and nicotine addiction in youth will enhance the ability of pediatric health care providers to more accurately evaluate their patients' smoking status and level of risk for addiction and long-term smoking.
Tobacco Use Trajectories
Young tobacco users generally follow 1 of 3 tobacco use trajectories: low frequency/quantity users (smoke only a few cigarettes per week or month or steadily decrease consumption from a low initial level), early increasers (rapidly increase consumption then continue increasing more slowly), and late increasers (begin smoking infrequently or at a low level of consumption, increase slowly until a later age, then increase sharply). 9,28-35 Escalating trajectories are predicted by poor academic performance and friends smoking and may also be predicted by male gender, older age, and parental smoking. 9 Factors that may protect against an escalating pattern of cigarette consumption include attending a school with a clear set of rules on smoking and having confidence in one's abilities to succeed at school. 31 Advice from clinicians may need to be adapted to stage in the onset process as well as trajectory pattern.
Early Onset of Nicotine Addiction
Some youth develop symptoms of addiction rapidly after their first exposure to nicotine, 36-38 at low levels of nicotine exposure, 39-41 or well before they consume a lifetime total of 100 cigarettes or become daily smokers. 37,38,42 Nicotine addiction symptoms (eg, cravings for cigarettes; feeling strong urges to smoke, irritable, nervous, restless or anxious when unable to smoke; feeling addicted to tobacco) can appear within 1 month of initiation of monthly smoking, 43 and the appearance of any symptom predicts failed quit attempts, continued smoking, and daily smoking. 36 Early onset of symptoms and appearance of symptoms before escalation in cigarette use have now been confirmed in 9 cohorts with .100 000 young smokers, including 2 nationally representative samples in the United States and New Zealand. [37] [38] [39] 41, 42, [44] [45] [46] Tobacco Use and Dependence
The relationship between tobacco use and addiction symptoms may be bidirectional; tobacco use causes symptoms, and early symptoms may promote escalation in use, leading to more symptoms. [47] [48] [49] The trajectory patterns described here predict the risk of developing addiction. In a cohort of adolescents assessed to age 28, there was a relationship between trajectory pattern and nicotine dependence in young adulthood. 46 Compared with low-use smokers, early and late stable users were 20 and 6 times more likely, respectively, to be dependent at age 26 to 28 years, although even smokers in the low-use trajectory who smoked as few as 2 to 4 cigarettes per week became dependent. 46 
Withdrawal
Withdrawal symptoms intensify through a predictable progression from "wanting" (a mild desire to smoke that is transitory and easily ignored), to "craving" (a strong, persistent, and intrusive urge to smoke), to "needing" (an unremitting urgency to smoke to restore "normal" function and emotional wellbeing). [50] [51] [52] [53] In some young smokers, the lag before experiencing withdrawal symptoms after smoking a cigarette can be as long as a week, but as they continue to smoke, the time lag diminishes. Shortening of the latency to withdrawal symptoms follows a predictable time course and leads to increased cigarette use. 53, 54 In adult smokers, this progression is correlated with higher scores on other measures of addiction 55 and with structural changes in brain areas related to craving. 56, 57 Cessation Although the desire to quit begins soon after initiation in many young smokers, repeated relapses lead to lack of confidence in the ability to quit and awareness that quitting is difficult. 58 Males, older youth, and those for whom cigarette package warnings induced fear are more likely to quit, whereas smokers who experience family stress, those who are worried about their weight or are overweight, those who use illicit drugs, and those who report symptoms of nicotine dependence are less likely to quit. 59 CYP2A6 activity leading to slow nicotine metabolism is associated with a higher probability of quitting. 60 
TREATING TOBACCO USE IN THE PEDIATRIC PRIMARY CARE SETTING Best Practices in Counseling
Although most youth smokers want and attempt to quit, 61 few seek assistance to do so, 61, 62 most quit attempts are unsuccessful, [63] [64] [65] and relapse is high. 66, 67 The Public Health Service Clinical Practice Guideline 68 states that counseling is effective in treating adolescent smokers and recommends counseling interventions to help them (strength of evidence = B, indicating that this service should be provided; an A level recommendation was not given because of mixed findings and low absolute abstinence rates in studies conducted to date). The counseling steps recommended follow the 5As model of care (Ask, Advise, Assess, Assist, Arrange follow-up), 68 which is a preventive services screening and brief counseling intervention that improves tobacco cessation rates in adults. 68 The 5As model adapted for youth (Fig 1) is described briefly here; for more details, see Supplemental Information. The first step is to Ask about and document tobacco use at all clinical encounters, including well-and sick-child visits, keeping in mind that many youth use both cigarette and noncigarette tobacco products concurrently. 7 Next, Advise cessation in a clear, strong manner, personalizing the risks of tobacco use, the benefits of quitting and expressing confidence in the tobacco user's ability to quit. The clinician should then Assess level of nicotine addiction, reasons for quitting, confidence in ability to quit, and readiness to make a quit attempt and/or initiate tobacco dependence treatment. In the Assist step, the clinician should initiate treatment, tailoring support to the adolescent's readiness to quit and severity of addiction.
Youth Ready to Quit
Provide youth ready to make a quit attempt with brief counseling, including tips to seek social support, learning from previous quit attempts, and discussing anticipated challenges and coping strategies. A key part of the Assist step is to provide concrete, readily accessible support and resources (Fig 1) . There are many resources available to clinicians including self-help materials, referral to statewide or national quitlines that provide free telephone counseling to assist tobacco users with cessation, smartphone applications, texting programs, and local community cessation resources (see Supplemental Information for details).
Youth Ready to Quit: Pharmacotherapy
Pharmacotherapy is currently not recommended for adolescents in the Public Health Service 2008 Tobacco Treatment Guideline because of insufficient evidence of effectiveness in published studies. 68 This conclusion is frustrating for many clinicians who seek a definitive recommendation for use and for those who have seen benefit to individual adolescents using nicotine replacement therapy (NRT) to quit tobacco. Indeed, surveys of youth document that many tobaccoaddicted youth use NRT without physician guidance. 69, 70 Additionally, the cut point for child and adolescent versus adult guidelines (age 18) is based on legal concerns rather than developmental milestones. Cognitive science and neuroanatomic changes associated with formal operational thought (age 14) and with maturation of higher executive function (age 24) are now well described 71 but have not been incorporated into clinical or behavioral counseling for smoking. Underage over-the-counter purchases and off-label prescriptions have not been studied outside of clinical trials, therefore accurate estimates of the frequency of use and its efficacy in such real-world use are not available. Given the importance of nicotine addiction, pharmacotherapy and combination pharmacotherapy deserve additional study in both adolescents and young adults. Until definitive studies are available, decisions about nicotine addiction pharmacotherapy should consider the evidence for efficacy in adults, the severity of the adolescent's addiction, the individual's experiences with cessation attempts, and his or her adherence to recommendations.
Pharmacotherapy may be considered by pediatric providers for youth who want to quit, have moderate or severe nicotine addiction, and accept the use of medication. NRT safety concerns for youth are similar to those for adults, including oral or skin irritation depending on the site of use, increased heart rate, and increased blood pressure. NRT has low abuse potential, given the way it is absorbed in the bloodstream. 72 Although some have raised concern about the potential of NRT to intensify nicotine addiction, this concern needs to be balanced against the high addictive potential of continued tobacco use. The goal of pharmacotherapy is to control nicotine withdrawal symptoms so that youth can quit more comfortably. Intensity and duration of therapy should be calibrated on the basis of the severity of nicotine addiction and adjusted on the basis of control of withdrawal symptoms to minimize the risk of relapse. 73 Close follow-up is important because nonadherence to treatment is common. In deciding on the use of pharmacotherapy, one needs to balance the relatively low risks of NRT against the substantial risk of harm to health caused by continued use of tobacco. 74 The presence of other chronic conditions, psychiatric illnesses, and other substance abuse can make treating nicotine addiction more difficult such that more intensive behavioral and pharmacologic therapy is needed.
Youth Not Ready to Quit
Clinicians should provide interventions to increase the likelihood of making a quit attempt in youth who are not ready to quit. These youth may lack information about the harmful effects of tobacco and the benefits of quitting. They may have concerns about quitting, perceive personal or social benefits from continued tobacco use, or they may lack confidence because they have relapsed after previous quit attempts. 75 Brief interventions based on motivational counseling principles 76 may be effective in increasing future quit attempts in both youth and adults. [77] [78] [79] [80] The motivational counseling intervention is reflected in the 5Rs: Relevance, Risks, Rewards, Roadblocks, and Repetition (Table 1) .
Arrange Follow-up
For all tobacco users, regardless of readiness to quit, Arrange follow-up, noting how and by when the individual should be contacted by the clinician or other provider from the practice to check on progress and provide continued support. For youth willing to make a quit attempt, arrange for follow-up contact within the first week of the quit date. For those not willing to attempt to quit, address tobacco use at the next clinic visit. For all of the 5A steps, intervening with youth is best done in a manner that maintains confidentiality and privacy, including speaking with the patient without the parent present.
The AAP Pediatric Research in Office Settings (PROS) network is currently testing the recommended 5As protocol (without pharmacotherapy) 68 in 152 pediatric primary care practices with 375 practitioners nationwide. 81, 82 The results, which will be available in late 2015, will provide invaluable information on the effectiveness of the 5As approach in youth and identify issues regarding implementation feasibility and protocol adherence.
Clinicians can consider delivering an abbreviated version of the 5As: Ask, Advise, Refer (AAR). 83 This model begins with the first 2 steps of the 5As model. If the patient is ready to quit, the clinician moves directly to referral to cessation resources. In this model, as with the 5As, follow-up is critical. AAR seeks to increase primary care referrals to existing resources including quitlines, Web resources, and apps that provide more intense support than is possible in clinical settings.
Best Office Practices
Several office practice-level changes have been shown to increase the likelihood of making counseling more routine. The first is to incorporate screening for tobacco use as standard care. Practices that care for youth should set up systems to identify and document tobacco use status and tobacco smoke exposure. Cues to inquire about these issues in electronic medical records are particularly effective in promoting delivery of prevention and cessation counseling in clinical settings. 68 Short screening tools to distinguish patients with a higher probability of becoming established smokers 84 may be helpful in directing counseling to those who would benefit most.
Another potential system-level change is development of patient registries for tobacco use, which would allow for technology-improved tracking of interventions and outcomes. Accountable Care Organizations are using care coordinators to manage other chronic diseases and the approach of delivering tobacco cessation messages through this model may be effective, although it has yet to be tested. The inclusion of tobacco cessation as a clinical quality measure for meaningful use escalates the importance of tobacco cessation for individual providers as well as hospital systems, helping promote effective system changes.
Other system-level changes are suggested by the movement toward creating patient-centered medical homes. These include optimizing office design to facilitate workflow and communication among staff and creating practice-based care teams in which all practice staff work to facilitate patient well-being. 85, 86 Training designated office staff to provide cessation counseling fits well with a care team approach. A national survey of primary care physician and practice factors found that having trained office staff available significantly increased physicians' advising patients to quit at each visit. 87 
Resources for Pediatric Providers
Up-to-date resources and tools for clinicians, educators, researchers, community advocates, and patients and families are available on the AAP Julius B. Richmond Web site at http://www.aap.org/richmondcenter. Table 2 summarizes the findings of scientific reviews on the effectiveness of youth tobacco cessation interventions published since 2003. Briefly, comprehensive Medline and SCOPUS searches were conducted by using the following key words: youth, adolescent, pediatric, tobacco smoking, cigarette, cessation, intervention, clinic, clinic-based, hospital, school, community (and truncated variants, such as cigar$ and adolesc$). In addition, the recent Surgeon General's Report and Cochrane Reviews were reviewed to check for omissions from the search. Two authors, KH and ST, reviewed the list to identify review papers (it was beyond the scope of this project to conduct another systematic review of the literature). These reviews collectively identified that although the evidence base is increasing, few findings are generalizable, and results on adherence to treatment protocols are disappointing. Several of the reviews made a resounding call for additional studies. 87 In general, studies have used age 18 to differentiate adolescent and adult studies and guidelines. However, in the past decade, continued advances in understanding neurobiology and cognitive development in youth have demonstrated that such a cutoff is not developmentally valid. Significant changes in decision-making occur over time, from the development of formal operational thought (usually around age 14-15) through maturation of higher executive function (decision-making, impulsivity, etc.), which continues to mature through age 24 to 25 years. 88, 89 This gradual development of neurobiological processes and cognitive control mechanisms over adolescence and early adulthood has implications for extrapolation of "adult" guidelines to young adults and older adolescents. 71 Existing reports including those we highlight in this 95 2012
TOBACCO INTERVENTION RESEARCH IN THE PAST DECADE AND RESEARCH GAPS
Efficacy and tolerability of pharmacotherapies to aid smoking cessation in adolescents Provide information on the pharmacologic action of each medication, the efficacy of each medication for adolescent smoking cessation, the tolerability of each medication based on reported adverse events, and compliance with the medication protocols. Reviewed 13 studies in total, from 1996 through 2011.
There is some evidence of efficacy of nicotine patch and bupropion at the end of treatment, but none of the medications included in this review were efficacious in promoting long-term smoking cessation among adolescent smokers. Participants had poor adherence to recommended dose or length of pharmacotherapy.
Kim et al, 97 2011
Effectiveness of pharmacologic therapy for smoking cessation in adolescent smokers: meta-analysis of randomized controlled trials
To evaluate the effectiveness of pharmacologic therapy for smoking cessation in adolescent smokers. Reviewed 6 studies also included in Bailey (2012). 95 No significant increase in abstinence rates was found in subgroup meta-analyses of studies with both short-term (#12 wk) and midterm (26 wk) follow-up periods. Although few serious adverse events were reported, there was no evidence directly linking these effects to the pharmacologic therapy used. The limited number of participants in published trials may have affected results. Karpinski et al, 96 2010
Smoking cessation treatment of adolescents Review pharmacotherapy literature regarding options for nicotine dependence in adolescents and discuss efficacy, safety, and other issues surrounding the use of bupropion and NRT specific to adolescents. Reviewed 9 RCTs.
Some evidence exists from short-term trials that bupropion and NRT are beneficial to aid adolescents in smoking cessation and to reduce the number of cigarettes smoked per day. Long-term quit rates in the pharmacotherapy trials have not been optimal; however, decreases in cigarettes smoked per day have been observed. Many studies with NRT had cessation rates ,15%. Additionally, although cessation of smoking occurred in many of the studies at the end of the treatment phase, longerterm follow-up of the patients demonstrated that many do not remain abstinent after stopping treatment.
review, have not considered these new developmental data and instead use age 18 as the definition of adulthood. Ideally, future evidence will take developmental trajectory data into account.
In 2003, the US Preventive Services Task Force (USPSTF) concluded that there was insufficient evidence to make recommendations on routine screening for tobacco use and dependence or interventions to prevent initiation and promote cessation in youth. 90 More recently, however, in 2013, it concluded that behavior-based interventions were effective in reducing initiation in nonsmoking youth, but neither behavior-based nor short-term bupropion interventions resulted in long-term effects on cessation in young smokers after the intervention ended. 91 The revised USPSTF recommendation suggests that primary care clinicians should provide education or brief counseling to prevent initiation in school-aged Some evidence to support the efficacy of certain school-and health care-based youth smoking interventions, but evidence for pharmacologic interventions was inconsistent. Abstinence rates in the intervention groups varied from 0% (nicotine patches) to 52% (curriculum-based information sessions). Statistically significant differences in abstinence rates in favor of the intervention group were reported in 3 of 4 RCTs assessing school-based interventions, all of which used CBT (2 RCTs) or a behavioral intervention (1 RCT). Only 2 of 4 trials that assessed health care-based interventions found a statistically significant difference in abstinence rates; this was in favor of a motivational interviewing intervention. Pbert et al, 10 2003
The state of office-based interventions for youth tobacco use
Report current tobacco treatment practices of pediatric and family practice clinicians. Discuss similarities and differences between adolescent and adult tobacco use, summarize research efforts to date and current cutting-edge research that may ultimately help to inform and guide clinicians. Present recommendations regarding treating tobacco use in youths.
Pediatricians and other clinicians can and should play an important role in treating tobacco dependence in youths. Pediatricians report a greater tendency to encourage youth not to start using tobacco than to intervene with those who already smoke. Clinicians report substantial rates of screening and lesser rates of counseling. However, they tend to overestimate their screening and counseling practices, both for smoking and for other preventive services, in comparison with patient reports. Clinical practice guidelines for the treatment of tobacco dependence in youth are needed to make treatment available to youth through the health care system. Coordinated efforts are needed at several levels of the health care system to maximize the likelihood that cessation interventions will be routinely delivered to youths. Important points of intervention include the clinician (eg, best practices for clinicians, clinician training, tools), organizational systems (eg, health care system changes, office systems), and policy (eg, reimbursement, incentives, performance measures).
CBT, cognitive behavioral therapy; RCT, randomized controlled trial.
youth (strength of evidence = B, indicating practices should provide this service). 27 Even minimal intervention such as mailing newsletters, activity guides, or tip sheets can result in reductions in initiation. 91 In contrast, evidence on the effectiveness of office-based cessation interventions for young smokers was limited, 91 in part because few studies tested officebased interventions in this age group or examined findings by level of smoking. 27 The 5 trials conducted in primary care or dental settings reviewed by the USPSTF 91 involved face-to-face interactions with health care providers including brief advice to quit smoking or counseling using the 5As model. 68 Three of the trials trained counselors to provide intensive counseling and telephone follow-up. [92] [93] [94] Overall, these studies suggest that behavioral interventions improve cessation.
Pharmacotherapy
Pharmacotherapy is effective in adult smokers, with increased benefit from combination pharmacotherapy. 68 Research on cessation interventions for youth, however, has focused primarily on behavioral interventions, with few trials on pharmacotherapy and none combining pharmacotherapies. Several reports have found that bupropion and NRT increase cessation in youth and reduce short-term daily consumption; however, none report effective longterm cessation in adolescents. [95] [96] [97] Among 13 studies reviewed, 95 courses of treatment were brief, and levels of nonadherence and rates of relapse on stopping treatment were high. For example, in 1 study, only 26% of adolescents used nicotine nasal spray daily, and 57% had stopped using the spray completely by the end of the first week. 98 In another, adherence to the nicotine patch was only 31%. 99 Two studies on pharmacotherapy combined with counseling in moderate to severely addicted adolescents achieved better levels of medication adherence than other studies and demonstrated a benefit. One found decreased rates of smoking during the 6-week course of bupropion but no difference compared with placebo after the medication was discontinued. 100 The second found substantial improvement in abstinence with the nicotine patch over placebo at end of treatment, but nicotine gum, marked by poor adherence, did not differ from placebo. 101 
Research Gaps
There are few rigorous randomized controlled trials of behavioral and/or pharmacotherapy interventions for adolescent tobacco treatment in the primary care setting. 27, 91 The need persists for research to inform practice-based youth tobacco interventions including high-quality replication and effectiveness studies in real-world primary care practice.
Research should include youth at various stages of tobacco use and addiction and should address the array of tobacco products now available (cigarettes, cigars, little cigars, smokeless tobacco, e-cigarettes, hookah, dissolvable tobacco, etc). Given that clinical encounters are limited in time, research must explore optimal dosage, brief clinician intervention, and clinician referrals to resources providing more intensive support. 27 An example is brief motivational interviewing, which can reduce cigarette smoking and increase serious attempts to quit in adolescents. 102, 103 Another promising area of research is the use of selfadministered computer-facilitated screening tools combined with brief clinician intervention. 104 Internetbased intervention, including smart phone applications and social media, may also have utility in clinical settings and warrant investigation. And lastly, given the significance of nicotine addiction, pharmacotherapy and combination pharmacotherapy deserve additional study in both adolescents and young adults.
TREATMENT OF TOBACCO USE IN PARENTS
Health care encounters in pediatric offices should routinely screen for and document sources of tobacco smoke exposure for the child. 105 Because parents are among the most important sources of a child's tobacco smoke exposure, 106 parental and caregiver smoking should be specifically queried. Inquiry can be verbal or in a self-report questionnaire administered in the clinic intake process. Suggested questions include the following 107 : (1) 
